Clinical Trial Update: Split-Dose R-CHOP for Older Adults With DLBCL [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting results for split-dose R-CHOP in older adults with Diffuse Large B-Cell Lymphoma; results were posted on 2026-01-29.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Diffuse Large B Cell Lymphoma, DLBCL | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-01-29